ALAINA GEISS: Open Payments
NPI 1588377378 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 96 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $2,493
Food & beverage: $2,276Education: $217
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $646 |
| UCB, Inc. | 15 | $347 |
| Regeneron Healthcare Solutions, Inc. | 9 | $278 |
| Galderma Laboratories, L.P. | 10 | $240 |
| PFIZER INC. | 7 | $211 |
| GENZYME CORPORATION | 9 | $204 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $152 |
| ABBVIE INC. | 11 | $142 |
| Lilly USA, LLC | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 1 | $67 |
Products named: TREMFYA, DUPIXENT, Bimzelx, NEMLUVIO, SKYRIZI, LITFULO, CIBINQO, ILUMYA.
Industry payments across NC — which companies pay providers there.
